DOI: 10.1055/s-00000069

Seminars in Liver Disease

Referenz

Cheng AL, Kang YK, Chen Z , et al.
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

Lancet Oncol 2009;
10 (1) 25-34

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in:
Aufrufen in: